Genetron Holdings Limited (“Genetron Health” or the “Company”) is a leading precision oncology platform company in China that specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The Company has developed a comprehensive product and service portfolio that cover the full-cycle of cancer care from early screening, to diagnosis and treatment recommendations, to continuous monitoring and continuous care.
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
A statement of beneficial ownership of common stock by certain persons
Registration of securities of foreign private issuers pursuant to section 12(b) or (g)
|EX-101.INS - XBRL INSTANCE DOCUMENT|